Irina Grigorescu[email protected]Prostate CancerHow deep learning can help predict cancer recurrenceProstate cancer is the second most common cancer affecting men worldwide, with an incidence rate of 13.5%, according to the World Health Organization. Expert pathologists diagnose this type of cancer through a transrectal biopsy, following the results of a prostate-specific antigen (PSA) test. The extracted samples of tissue are examined under a microscope and, if cancerous cells are found, divided into risk groups assigned through the Gleason score. This grading system is considered the gold standard in cancer medicine, as it determines the aggressiveness of prostate cancer and helps doctors establish the right course of treatment.February 16, 2020Page 1 of 1Top StoriesGene silencing and gene editingEngineered Cas clears barrier to antiviral CRISPR therapiesResearchers have engineered a Cas enzyme to enhance activity against RNA viruses, resulting in a system that completely blocked the replication of various SARS-CoV-2 strains.Artificial IntelligenceAI-powered endoscope doubles detection of high-risk esophageal lesionsMergers & AcquisitionsBruker to acquire NanoString for $392.6MTrends and FinanceDermTech receives delisting warning from NasdaqSponsor ContentVisit our Molecular Diagnostics Community